companydata.dkcompanydata.dk

Pharma Equity Group A/S: Financial statements 2014

CVR: 26791413

Source: annual report 2014, Danish Business Authority

01/01/2014 – 31/12/2014

Pharma Equity Group A/S (CVR 26791413) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 0 and a net result of DKK -5,930,000. Equity in the 2014 report amounted to DKK 97,950,000. The solvency ratio was 79%.

Revenue
DKK 0
Profit/Loss
DKK -5,930,000
Equity
DKK 97,950,000
Total Assets
DKK 123,971,000

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

Staffan Mattson joins Pharma Equity Group A/S as adm. dir.Jul 11, 2014

As of July 11, 2014, Staffan Mattson is registered as adm. dir. of Pharma Equity Group A/S.

Morten Jensen steps down as adm. dir. of Pharma Equity Group A/SJul 11, 2014

As of July 11, 2014, Morten Jensen has stepped down as adm. dir. of Pharma Equity Group A/S.

Pharma Equity Group A/S: The 2013 annual report is outJun 23, 2014

Pharma Equity Group A/S has published its annual report for 2013.

Claus Abildstrøm joins the board of Pharma Equity Group A/SApr 30, 2014

As of April 30, 2014, Claus Abildstrøm has joined the board of directors of Pharma Equity Group A/S.

Gert Michael Mortensen joins the board of Pharma Equity Group A/SApr 30, 2014

As of April 30, 2014, Gert Michael Mortensen has joined the board of directors of Pharma Equity Group A/S.

Peer Thomas Borg joins the board of Pharma Equity Group A/SApr 30, 2014

As of April 30, 2014, Peer Thomas Borg has joined the board of directors of Pharma Equity Group A/S.

Frederik Steen Westenholz leaves the board of Pharma Equity Group A/SApr 30, 2014

As of April 30, 2014, Frederik Steen Westenholz has left the board of directors of Pharma Equity Group A/S.

Vilhelm Boas leaves the board of Pharma Equity Group A/SApr 30, 2014

As of April 30, 2014, Vilhelm Boas has left the board of directors of Pharma Equity Group A/S.

Henrik Faber Andersen leaves the board of Pharma Equity Group A/SApr 30, 2014

As of April 30, 2014, Henrik Faber Andersen has left the board of directors of Pharma Equity Group A/S.

Morten Jensen joins Pharma Equity Group A/S as adm. dir.Apr 30, 2014

As of April 30, 2014, Morten Jensen is registered as adm. dir. of Pharma Equity Group A/S.

About Pharma Equity Group A/S

Pharma Equity Group A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2002. The company is registered under the industry Investering for egen regning. The company was previously named BLUE VISION A/S and GUDME RAASCHOU VISION A/S. The management consists of Christian Henrik Tange. The board consists of Christian Vinding Thomsen (chair), Charlotte Pahl, Lars Rosenkrantz Gundorph and Omar Siraj M Qandeel. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 0. Equity in the 2025 report amounted to DKK 25,472,000.

Source: annual report 2025, Danish Business Authority